Healthcare News and Research

Latest Healthcare News and Research

Biotin benefits ‘clinically relevant’ in progressive multiple sclerosis

Patients with progressive multiple sclerosis and their clinicians see clear improvements during treatment with a high dose of biotin, show further results from the phase III trial of the therapy.

22 Jun 2015

Opioid offers pain relief for Parkinson’s patients

Prolonged-release combined oxycodone/naloxone may provide relief for patients with severe pain related to Parkinson’s disease, a double-blind randomised trial shows.

22 Jun 2015

Centene recognized with Auburn University's Corporate Anti-Bullying Hero Award

Centene Corporation announced today that the company received the Corporate Anti-Bullying Hero Award at Auburn University's Anti-Bullying Summit in Peachtree City, Georgia.

22 Jun 2015

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Benitec Biopharma is pleased to announce the launch of a new exploratory cellular therapy program including exosome-based delivery utilising the Company's proprietary ddRNAi technology. Entry into these areas have been facilitated by the commencement of a collaboration with UK-based stem cell therapeutics company, ReNeuron.

22 Jun 2015

Coventry University receives funding to provide new research master’s programme for healthcare professionals

Healthcare professionals in the West Midlands will be funded to take up a new research master’s programme thanks to a prestigious grant being awarded to Coventry University.

22 Jun 2015

Oraya IRay Radiotherapy System for AMD treatment receives Silver award at MDEA 2015

Oraya Therapeutics Inc.and Bridge Design announced today that the Oraya IRay Radiotherapy System has won the Silver award in the radiological and electromechanical devices category of the 18 Annual Medical Design Excellence Awards (MDEA).The winners were announced at a ceremony in New York City at the Jacob Javits Center in conjunction with the MD&M East event.

22 Jun 2015

Trevelino/Keller selected as ExamMed's principal integrated PR and marketing agency

ExamMed, the only universal healthcare technology platform, offering providers an ideal patient-centered, complete model of care, both virtual and in-office, recently selected Trevelino/Keller as its principal integrated PR and marketing agency.

22 Jun 2015

MESA announces acquisition of Sigil

MESA Group Holdings, a Pantheon Healthcare Group company, today announced the acquisition of French diagnostic imaging service provider Sigil. Complementing MESA's recent business expansion into France with its core Multi-Vendor Service (MVS) and Managed Equipment Service (MES) offerings, the acquisition of Sigil will accelerate the development and adoption of more efficient asset management and medical equipment maintenance service solutions for public and private sector hospitals and imaging centres.

22 Jun 2015

Hormones used in breast cancer treatment could affect disease progression, outcomes in some patients

Recently, researchers have discovered that the hormone progesterone, an ingredient in contraceptives and menopausal hormone replacement therapies, might stimulate the growth of breast cancer cells that are resistant to anti-estrogen therapy and chemotherapy.

22 Jun 2015

Sysmex unveils latest series of haematology analysers at IFCC congress

The Sysmex Corporation, the global leader in haematology, unveiled its latest series of haematology analysers at the annual IFCC congress, EuroMedLab JIB in Paris today. The XN-L series follows in the footsteps of its game-changing big brother, the XN-Series. The new, smaller XN-L Series makes top quality haematology available for all.

From Sysmex America, Inc. 22 Jun 2015

Jopari announces immediate availability of Jopari Attach at HFMA

"The need Healthcare Providers have to make supporting documentation available to Payers for both administrative and clinical purposes is increasing" states Steve Stevens, CEO of Jopari Solutions.

22 Jun 2015

PD linked to increased cancer risk in Asian population

A Taiwanese population-based cohort study reports an increased risk of most cancers in patients with Parkinson’s disease, contrasting with findings in Western populations.

19 Jun 2015

Nonmotor features may predict PD progression

The presence of mild cognitive impairment, orthostatic hypotension, and rapid eye movement sleep behaviour disorder may identify a subset of Parkinson’s disease patients with a poor prognosis, research suggests.

19 Jun 2015

Improved birth control advice reduces unintended pregnancy rate among young women

Providing health workers with training on how to educate young women about intrauterine devices (IUDs) and contraceptive implants reduced the rate of unintended pregnancy by almost half in a study of women seeking family planning services.

19 Jun 2015

University of Utah-led study suggests that readmission to same hospital important for recovery

Up to 22 percent of surgical patients experience unexpected complications and must be readmitted for post-operative care. A study led by the University of Utah suggests that returning to the same hospital is important for recovery. Readmission to a different hospital was associated with a 26 percent increased risk for dying within 90 days.

19 Jun 2015

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Eli Lilly and Company announced that The Lancet Oncology has published results of the Phase III REACH trial that evaluated CYRAMZA (ramucirumab) as a second-line treatment for people with hepatocellular carcinoma (HCC), also known as liver cancer. While the REACH trial's primary endpoint of overall survival favored the CYRAMZA arm, it was not statistically significant.

19 Jun 2015

New study predicts outcomes of CV patients using polypill intervention

A new study published in the journal BMJ Open (May 2015) has demonstrated that the improved treatment adherence achievable using a fixed-dose combination polypill (atorvastatin, ramipril and low-dose aspirin) to prevent recurring myocardial infarction, can avoid up to 15% more fatal and non-fatal CV events, conferring potential savings to healthcare systems.

19 Jun 2015

ARN announces launch of ReSTART online recovery resource for rehabilitation

The Association of Rehabilitation Nurses today announced the launch of the brand-new ReSTART online recovery resource for rehabilitation. The ReSTART site provides key information for those starting the journey of rehabilitation, as well as their family members, loved ones, and caretakers.

19 Jun 2015

Lilly announces positive results from LY2951742 Phase 2b study in patients with episodic migraine

Eli Lilly and Company announced today that its investigational medicine for prevention of migraine (LY2951742, a CGRP neutralizing antibody) met the primary endpoint in a Phase 2b study in episodic migraine.

19 Jun 2015

Taranis protein could hold key to a good night's sleep

Most of us need seven to eight hours of sleep a night to function well, but some people seem to need a lot less sleep. The difference is largely due to genetic variability. In research published online June 18th in Current Biology, researchers report that two genes, originally known for their regulation of cell division, are required for normal slumber in fly models of sleep: taranis and Cyclin-dependent kinase 1 (Cdk1).

19 Jun 2015

Healthcare News and Research

Latest Healthcare News and Research

Biotin benefits ‘clinically relevant’ in progressive multiple sclerosis

Opioid offers pain relief for Parkinson’s patients

Centene recognized with Auburn University's Corporate Anti-Bullying Hero Award

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Coventry University receives funding to provide new research master’s programme for healthcare professionals

Oraya IRay Radiotherapy System for AMD treatment receives Silver award at MDEA 2015

Trevelino/Keller selected as ExamMed's principal integrated PR and marketing agency

MESA announces acquisition of Sigil

Hormones used in breast cancer treatment could affect disease progression, outcomes in some patients

Sysmex unveils latest series of haematology analysers at IFCC congress

Jopari announces immediate availability of Jopari Attach at HFMA

PD linked to increased cancer risk in Asian population

Nonmotor features may predict PD progression

Improved birth control advice reduces unintended pregnancy rate among young women

University of Utah-led study suggests that readmission to same hospital important for recovery

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

New study predicts outcomes of CV patients using polypill intervention

ARN announces launch of ReSTART online recovery resource for rehabilitation

Lilly announces positive results from LY2951742 Phase 2b study in patients with episodic migraine

Taranis protein could hold key to a good night's sleep

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in